Xiaomeng Wang

422 total citations
12 papers, 278 citations indexed

About

Xiaomeng Wang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Xiaomeng Wang has authored 12 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Xiaomeng Wang's work include interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (3 papers) and Immune Cell Function and Interaction (3 papers). Xiaomeng Wang is often cited by papers focused on interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (3 papers) and Immune Cell Function and Interaction (3 papers). Xiaomeng Wang collaborates with scholars based in China, United States and India. Xiaomeng Wang's co-authors include Xiubao Ren, Baohong Yang, Bo Zhong, Zhigao Xu, Dandan Lin, Peng Wang, Wei Yang, Chen Dong, Jing‐Yuan Fang and Bin Xiong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and International Journal of Cancer.

In The Last Decade

Xiaomeng Wang

10 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomeng Wang China 8 157 130 97 60 24 12 278
Yiran Wang China 9 138 0.9× 149 1.1× 104 1.1× 47 0.8× 36 1.5× 22 325
Benfan Wang Canada 8 185 1.2× 115 0.9× 98 1.0× 80 1.3× 21 0.9× 12 325
Ajeya Nandi India 9 170 1.1× 131 1.0× 154 1.6× 84 1.4× 18 0.8× 20 356
Kebria Hezaveh Canada 8 111 0.7× 215 1.7× 105 1.1× 33 0.6× 26 1.1× 11 337
Jung‐Ah Kang South Korea 11 177 1.1× 190 1.5× 81 0.8× 48 0.8× 52 2.2× 27 399
Pengfei Zhou China 8 130 0.8× 175 1.3× 101 1.0× 67 1.1× 24 1.0× 18 361
Jikun Zha United States 7 188 1.2× 152 1.2× 52 0.5× 53 0.9× 24 1.0× 9 314
Sara Hildebrand United States 9 151 1.0× 134 1.0× 47 0.5× 46 0.8× 12 0.5× 13 303
Hanxi Xiao United States 10 109 0.7× 167 1.3× 82 0.8× 47 0.8× 22 0.9× 19 309
Saumya Maru United States 8 84 0.5× 203 1.6× 69 0.7× 60 1.0× 25 1.0× 12 328

Countries citing papers authored by Xiaomeng Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaomeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomeng Wang more than expected).

Fields of papers citing papers by Xiaomeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomeng Wang. The network helps show where Xiaomeng Wang may publish in the future.

Co-authorship network of co-authors of Xiaomeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomeng Wang. A scholar is included among the top collaborators of Xiaomeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomeng Wang. Xiaomeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hou, Peili, Yan Gao, Xiaomeng Wang, et al.. (2024). PBLD enhances antiviral innate immunity by promoting the p53–USP4–MAVS signaling axis. Proceedings of the National Academy of Sciences. 121(49). e2401174121–e2401174121. 3 indexed citations
2.
He, Hongbin, Xiaomeng Wang, Peili Hou, et al.. (2024). PBLD enhances antiviral innate immunity by promoting the p53-USP4-MAVS signaling axis.. UNC Libraries.
3.
Song, Weihua, et al.. (2022). Targeting Inflammation to Control Tissue Fibrosis. 6–6.
4.
Chen, Xueying, Wenyong Yang, Hui Yu, et al.. (2020). The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response. Cellular and Molecular Immunology. 18(8). 1981–1994. 21 indexed citations
5.
Wang, Xiaomeng, Yin Zhao, Zhigao Xu, et al.. (2020). The deubiquitinase USP25 supports colonic inflammation and bacterial infection and promotes colorectal cancer. Nature Cancer. 1(8). 811–825. 60 indexed citations
6.
Zhang, Meng‐Xin, Man Zhang, Xiaomeng Wang, et al.. (2019). USP20 Promotes Cellular Antiviral Responses via Deconjugating K48-Linked Ubiquitination of MITA. The Journal of Immunology. 202(8). 2397–2406. 27 indexed citations
7.
Guo, Liang, Cheng Xiang, Hongyu Chen, et al.. (2019). Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis. Cancer Letters. 452. 213–225. 68 indexed citations
8.
Qian, Danwen, Hongliang Liu, Xiaomeng Wang, et al.. (2018). Potentially functional genetic variants in the complement‐related immunity gene‐set are associated with non‐small cell lung cancer survival. International Journal of Cancer. 144(8). 1867–1876. 16 indexed citations
9.
Yao, Min, Feng Gao, Xiaomeng Wang, et al.. (2017). Nox4 is involved in high glucose-induced apoptosis in renal tubular epithelial cells via Notch pathway. Molecular Medicine Reports. 15(6). 4319–4325. 23 indexed citations
10.
Wang, Xiaomeng, Wenwen Yu, Hui Li, et al.. (2013). Can the dual-functional capability of CIK cells be used to improve antitumor effects?. Cellular Immunology. 287(1). 18–22. 28 indexed citations
11.
Wang, Xiaomeng, Jinpu Yu, Hui Li, et al.. (2013). Comparison of four kinds of NK cell in vitro expansion methods. 20(3). 336–341. 4 indexed citations
12.
Yang, Baohong, Xiaomeng Wang, & Xiubao Ren. (2012). Amino Acid Metabolism Related to Immune Tolerance by MDSCs. International Reviews of Immunology. 31(3). 177–183. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026